SARCINA, TOMMASO
 Distribuzione geografica
Continente #
AS - Asia 59
NA - Nord America 49
EU - Europa 42
SA - Sud America 6
AF - Africa 2
Totale 158
Nazione #
US - Stati Uniti d'America 45
IT - Italia 24
SG - Singapore 23
VN - Vietnam 14
BD - Bangladesh 7
CN - Cina 7
BR - Brasile 4
FR - Francia 3
HK - Hong Kong 3
RU - Federazione Russa 3
DE - Germania 2
GB - Regno Unito 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
CA - Canada 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
IN - India 1
JM - Giamaica 1
JP - Giappone 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
UA - Ucraina 1
Totale 158
Città #
San Jose 13
Singapore 9
Los Angeles 5
Nocera Inferiore 5
Ashburn 4
Council Bluffs 4
Hanoi 4
Ho Chi Minh City 3
Hong Kong 3
Lauterbourg 3
Montoro 3
New York 3
Atlanta 2
Beijing 2
Florence 2
Mexico City 2
Naples 2
San Giuseppe Vesuviano 2
Amsterdam 1
Ankara 1
Arganda 1
Batna City 1
Biên Hòa 1
Brooklyn 1
Bắc Giang 1
Caçador 1
Cherkasy 1
Chicago 1
Cookeville 1
Crumpler 1
Dallas 1
Denver 1
El Jadida 1
Frankfurt am Main 1
Gainesville 1
Go Vap 1
Hải Dương 1
Ituzaingó 1
Kingston 1
Maceió 1
Magé 1
Manassas 1
Memphis 1
Newark 1
Oslo 1
Phillaur 1
Poplar 1
Quito 1
Quận Ba 1
Regina 1
Rockford 1
Rome 1
Stockholm 1
São Paulo 1
Tokyo 1
Ulu Tiram 1
Vilnius 1
Virginia Beach 1
Warsaw 1
Totale 112
Nome #
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years 59
A Novel Municipal-Level Approach to Uncover the Hidden Burden of Hepatitis C: A Replicable Model for National Elimination Strategies 55
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers 39
Driving HCV Elimination Through Dedicated Hospital-Based Teams and Pathways: A Retrospective and Prospective Study 7
Weight Loss-Induced Metabolic Remodeling in Metabolic dysfunction-associated steatotic liver disease: A Cohort Study Stratified by Genetic Risk 3
Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 1
Totale 164
Categoria #
all - tutte 435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202516 0 0 0 0 0 6 3 2 1 0 2 2
2025/2026148 2 3 2 5 36 16 17 13 12 18 14 10
Totale 164